Idorsia pharmaceuticals

Quote
















anonymous said:
Wow awesome take! Yeah they sold their first company for 30 bil what a bunch of losers. Moron
Click to expand...

Right. Idorsia is doing so well that its contracted sales staff is in constant turmoil. Or didn’t you know that, fool? They launched against an existing product in a field dominated by generics with almost zero managed care coverage with higher pricing than the branded market leader in the class (which wasn’t doing so well itself). The last vestiges of their former company are completely gone, and their pipeline consists of hand-me-downs that J&J rejected in the purchase. So do tell us how they geniuses.
 




anonymous said:
Right. Idorsia is doing so well that its contracted sales staff is in constant turmoil. Or didn’t you know that, fool? They launched against an existing product in a field dominated by generics with almost zero managed care coverage with higher pricing than the branded market leader in the class (which wasn’t doing so well itself). The last vestiges of their former company are completely gone, and their pipeline consists of hand-me-downs that J&J rejected in the purchase. So do tell us how they geniuses.
Click to expand...
 




anonymous said:
Right. Idorsia is doing so well that its contracted sales staff is in constant turmoil. Or didn’t you know that, fool? They launched against an existing product in a field dominated by generics with almost zero managed care coverage with higher pricing than the branded market leader in the class (which wasn’t doing so well itself). The last vestiges of their former company are completely gone, and their pipeline consists of hand-me-downs that J&J rejected in the purchase. So do tell us how they geniuses.
Click to expand...
I don’t usually engage with idiots on here but what the hell I’m bored. How are they geniuses? Well they started a company with somewhat of a shaky molecule, had great success, came out with a much better drug, introduced a game changing drug that was far superior to oral trep. Began discussing a buyout with JNJ but spurned them initially which brought Novartis in as a suitor let those two bid the price up and sold the company for 30 bil. Also as part of the deal made JNJ seed their next venture with a billion and took the most advanced 5 agents for free in the pipeline to do it all over again. I’d say that’s a pretty genius move. They aren’t pinning their future on this sleep drug. The last vestiges of the old company are gone? Oh you mean the two blockbuster meds in a rare disease still enjoying double digit growth every year. Another awesome take.
 




anonymous said:
I don’t usually engage with idiots on here but what the hell I’m bored. How are they geniuses? Well they started a company with somewhat of a shaky molecule, had great success, came out with a much better drug, introduced a game changing drug that was far superior to oral trep. Began discussing a buyout with JNJ but spurned them initially which brought Novartis in as a suitor let those two bid the price up and sold the company for 30 bil. Also as part of the deal made JNJ seed their next venture with a billion and took the most advanced 5 agents for free in the pipeline to do it all over again. I’d say that’s a pretty genius move. They aren’t pinning their future on this sleep drug. The last vestiges of the old company are gone? Oh you mean the two blockbuster meds in a rare disease still enjoying double digit growth every year. Another awesome take.
Click to expand...

RIGHT…it’s old “blockbuster” is now generic. It’s other “blockbuster” is so heavily PA’d that another generic is in its way. It’s current branded product in the US is a loss leader, it’s next big “schlockbuster” will be a 9th line “in case nothing else works” POS so heavily PA’d POS that not even JNC will touch it for guidelines and then…????? You jerkoff…Doctor and Doctoress Clozell are up to their usual bullcrap…shift and blame until the heat comes, hope to sell and then hope SEC doesn’t get them…or did you think nobody remembers how the Japanese company they tried to screw over on fasudil—where they ended up paying almost half a billion dollars up their asses because they tried to fuck over CoTherix’s deal simply went away empty handed? They got properly f*cked on that—and more will follow, schmuckie!
 




Ok I get it now. You’re one of the ones that couldn’t hack it with Actelion and still bitter. Btw, wasn’t talking about Tracleer as one of the current blockbusters dumbass. That would be Uptravi. Despite your ridiculous claims Opsumit doing fine too. Anyway, sorry you sucked and best to you in whichever sample dropping endeavor you wound up in or more likely now Uber or DoorDash.
 




Top Bottom
Back
Quote